Click for contact details

News

24th March 2014
Horizon completes landmark UK IPO
Please see attached press release for the full announcement.
Read this article

19th March 2014
eZono 4000 with needle guidance approved in US
Please see attached press release for the full announcement.
Read this article

3rd February 2014
MVM - Cara Therapeutics raises $55m on NASDAQ
MVM - Cara Therapeutics raises $55m on NASDAQ
Read this article

10th December 2013
eZono 4000 with needle guidance approved in Europe
eZono 4000 with needle guidance approved in Europe
Read this article

2nd October 2013
Xention partners its lead atrial fibrillation drug with Servier
Xention and Servier announce a cardiovascular collaboration to further develop a selective Kv1.5 modulator for the treatment of atrial fibrillation
Read this article

News Archive
Last 5 Articles | Next 5 Articles

Article image
 22nd November 2011
Health Information Announces Investment from MVM Life Science Partners

Health Information, the dominant provider of point of dispensing messaging in the UK, announces that it has secured a first round of funding from MVM Life Sciences LLP (“MVM”). MVM is a leading EU/US life science venture capital fund with $500m under management. This financing will support the continued development of the company’s pharmacy network, strengthening of the pharmaceutical sales team and preparations for EU roll-out of the business.

Health Information is a pioneer in this field, and is launching first-to-market clinical messaging services within 40% of retail pharmacies and 50% of hospital pharmacies. Over the last three years Health Information has completed over 40 customer projects for 18 of the top 20 UK pharmaceutical companies.

Health Information’s mission is to enhance patients’ lives by enabling point of dispensing intervention. It has already supported millions of patients, and continues to pioneer new and innovative services, via its network of thousands of independent and hospital pharmacies.

Through its point of dispensing messaging, Health Information has repeatedly proven that it supports patients understanding of their conditions, improves compliance with their medication and drives strong growth of customer brands in a measurable fashion.

Mr Thomas Casdagli, from MVM, has joined the board. Mr Casdagli has over 9 years of healthcare investment experience and currently serves as a Member of the Boards of Alliance Pharma plc and Lombard Medical Technologies plc.

Mr Casdagli said, “We are delighted to be making this investment. Health Information’s position in the market and track record of ground-breaking, effective innovations, represent a unique opportunity. We are excited about the prospects for growth, both within the UK and continental Europe.”

Dr Grace Lomax, Founder of Health Information said “We are delighted to partner with a specialised healthcare investor like MVM to support the continuing growth of our business. MVM clearly recognise the value of clinical messaging in pharmacy and its ability to provide our partners with superior returns than traditional marketing and sales approaches.”

Associated Links
Visit Health Information Limited
Downloads
Full Press Release